Low libido in older women not just down to menopause

Menopause marks the end of a woman’s reproductive years. Along with it, comes various effects, including irregular to the complete cessation of periods, insomnia, mood swings, irritability, hot flushes, and decreased sexual drive.

Now, women older than 60 may experience a decrease in sexual drive and libido, and it’s not just because of menopause, a new study suggests.

A team of researchers at the University of Pittsburgh School of Medicine revealed that women in their 60s report many reasons behind a lack of libido. Published in the journal Menopause, the qualitative study explored on the possible reasons for their lack of desire for sex. They found that aside from going through menopause, there are a multitude of other factors affecting libido, including postmenopausal vaginal symptoms, fatigue or body pain, body image, life stressors, and erectile dysfunction in their partners.

Study explains why women in their 60s have low libido

A qualitative study by researchers at the University of Pittsburgh School of Medicine found that women in their 60s report various reasons behind why they lack libido.

The study, published today in Menopause, distilled interviews with dozens of women about their lack of desire for sex into several major themes -; including sexual dysfunction in their partners.

If a woman is having sexual problems, what’s going on with her partner may be contributing. Sex doesn’t occur in a vacuum.”

Holly Thomas, M.D., M.S.

Thomas is the lead author and an.assistant professor of medicine at Pitt.

New link between two important products of nitric oxide discovered

Ever since three US-based researchers working independently unveiled the role of nitric oxide in mediating blood vessel dilation, endothelial cell contraction and smooth muscle relaxation, their discoveries have served as a basis for novel treatments for high blood pressure and erectile dysfunction, among other conditions.

The Nobel Prize in Physiology or Medicine in 1998 was awarded jointly to Robert F. Furchgott, Louis J. Ignarro and Ferid Murad for groundbreaking research of nitric oxide conducted during the 1970s and 1980s. Their work paved the way for the development of redox biochemistry, an entirely new research field. Nitric oxide is a free radical that has been shown to play a key role in the body’s defenses against tumors and bacteria, as well as in inflammatory and wound healing processes.

Web-based, digital-app birth control prescription services appear to be overall safe and efficient

Web-based and digital-app services that offer oral contraception appear to be overall safe and efficient, according to the findings of a secret-shopper-style study conducted by researchers at Harvard Medical School and UC Davis that analyzed the birth control prescription services of nine U.S. vendors.

The results, published Sept. 26 in The New England Journal of Medicine, offer a measure of reassurance amid concerns over the safety and reliability of a rapidly growing model of care delivery that gives individuals online access to treatments ranging from birth control and erectile dysfunction medication to hair-loss drugs.

Men with prostate cancer want access to female doctors

Sep 25 2019

Malecare, America’s largest men’s cancer support network, this week announced the world’s first prostate cancer patient conference to feature an all-female faculty featuring twelve of the U.S.A.’s top prostate cancer clinicians. The Prostate Cancer Patient Conference is a day-long event taking place in New York City on October 5th.

Less than 1% of all urologists are women who treat prostate cancer. Sexism in cancer care is a barrier for patients seeking optimal care. Malecare is trying to reduce this disparity, starting with this groundbreaking conference. Female doctors tend to listen more attentively to their male patients, according to men in our support groups. It’s possible that female doctors feel less competitive and more compassionate towards men suffering the side effects of prostate cancer treatment.”

Oldies who have sex happier and healthier, says new study

Who says sex is just for younger people? A new study gives this popular belief the lie, showing that while older people may have less frequent sex, it is still important for their happiness and physical health.

Neither do they lack the motivation or physical capability, as many think. The study titled, ‘Sexual Activity is Associated with Greater Enjoyment of Life in Older Adults’, is published in the journal Sexual Medicine.

Men with prostate cancer can have healthy sex lives after surgery

There’s a perception that surgery to treat prostate cancer will spell the end of a man’s sex life.

And while that often used to be the case, survivorship programs, like the one at the University of Michigan Rogel Cancer Center, offer counseling and interventions to promote sexual recovery after cancer treatment.

“Prostate cancer, especially if it’s caught early, is a highly treatable disease,” says Daniela Wittmann, Ph.D., LMSW, an associate professor of urology and social work at U-M, and a certified sex therapist with more than 30 years of experience. “But that also means that men are often living for a long time and dealing with the side effects of treatment.”

Purveyors of black-market pharmaceuticals target immigrants

The bootleg medications were smuggled across the border and sold to mostly Latino immigrants in public spaces throughout Los Angeles — at swap meets, parks, beauty salons and makeshift stands outside mom-and-pop grocery stores.

The drugs were cheap, and the customers — mostly from Mexico and Central America — did not need prescriptions to buy them. Some of the products featured brand names and colorful packaging that immigrants knew well from their home countries — including Ciprofloxacina, a potent antibiotic, and Dolo Nervi Doce — translated as “Pain Nerve 12” — an injectable B-complex vitamin taken for fatigue.

Gold nanoparticles used successfully in prostate tumour trial

Researchers at the Icahn School of Medicine, Mount Sinai, New York have reported a pilot clinical trial with a “nanoparticle-based photothermal cancer therapy” for prostate cancers. Their work with this targeted therapy is published in a study titled, “Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study,” in the latest issue of the journal Proceedings of National Academy of Science.

Art Rastinehad, DO, Associated Professor of Urology and Radiology at the Icahn School of Medicine at Mount Sinai, is leading the first clinical trial of gold nanoparticles to treat prostate cancer.

Art Rastinehad, DO, Associated Professor of Urology and Radiology at the Icahn School of Medicine at Mount Sinai, is leading the first clinical trial of gold nanoparticles to treat prostate cancer.

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the journal Proceedings of the National Academy of Sciences. This treatment could offer patients a targeted therapy option that would preserve critical structures within the prostate, thus avoiding side effects associated with whole-gland treatment such as prostatectomies.